Sharemaestro Newsreel

Emergent BioSolutions Inc. 2026: Revenue $234.3M, EPS ($3.49) — 10-Q Summary

Emergent BioSolutions Inc. reported its second-quarter 2026 results, with revenue increasing to $234.3M from $140.9M year-over-year. Despite this growth, the company recorded a net loss of ($180.2M) and diluted EPS of ($3.49), primarily due to a $191M non-cash impairment on NARCAN® intangible assets. The …

ANI Pharmaceuticals (ANIP) Q2 Earnings: What To Expect

Earnings Flash (PBH) Prestige Consumer Healthcare Inc. Reports Q1 Revenue $265.7M, vs. FactSet Est of $250.3M

Prestige Consumer Healthcare Inc. (PBH) reported its Q1 revenue of $265.7 million, surpassing FactSet's estimate of $250.3 million. This positive earnings flash was published on August 6, 2026, and also follows an earlier report of the company raising its earnings guidance for fiscal year …

Prestige Consumer Healthcare Inc. Reports Fiscal 2027 First Quarter Results

Prestige Consumer Healthcare Inc. reported strong first-quarter fiscal 2027 results, exceeding sales and earnings expectations with a revenue of $265.7 million, up 6.5%, and organic sales growth of 3.2%. The company closed the Breathe Right® and LaCorium acquisitions, which contributed to its performance and …

Alpha Teknova, Inc. reports results for the quarter ended June 30 - Earnings Summary

Alpha Teknova, Inc. has released its earnings summary for the quarter that ended on June 30. The article, sourced from Reuters via Refinitiv, provides a brief announcement of these financial results. Users can access the full report on TradingView, which aggregates content from various …

supernus pharmaceuticals, inc. Positive Earnings Pre-Announcements

Supernus Pharmaceuticals, Inc. announced positive earnings pre-announcements, updating its fiscal year 2026 revenue range from $840-$870 Million to $860-$890 Million. The company has been active in mergers and acquisitions, including a proposed merger with Indivior and an acquisition of Sage Therapeutics, and has seen …

Pacer Advisors Inc. Buys 83,739 Shares of Amphastar Pharmaceuticals, Inc. $AMPH

Pacer Advisors Inc. increased its stake in Amphastar Pharmaceuticals by 47.1% in the first quarter, purchasing 83,739 additional shares, bringing its total holdings to 261,483 shares valued at approximately $5.1 million. Despite this institutional interest, analyst sentiment remains cautious with a "Reduce" consensus rating …

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Given Average Recommendation of "Moderate Buy" by Brokerages

Eton Pharmaceuticals (NASDAQ:ETON) has received an average "Moderate Buy" rating from brokerages, with an average 12-month price target of $52.50. Despite company insiders selling approximately $4.85 million worth of shares, institutional investors have increased their stakes. The company's recent quarterly revenue exceeded expectations, but …

Evotec and Odyssey Pair AI With Lab Tests for Immune Diseases

Evotec has announced an AI-enabled R&D collaboration with Odyssey Therapeutics to discover new small molecule treatments for autoimmune and inflammatory diseases. The partnership will leverage Evotec's integrated discovery platform, advanced screening, and AI-driven data science to accelerate the identification of validated hit series. Evotec …

Rockwell Medical (RMTI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Rockwell Medical (RMTI) is expected to report a year-over-year increase in earnings on higher revenues for the quarter ended June 2026, though analysts have revised the EPS estimate 30% lower. The company has an Earnings ESP of 0% and a Zacks Rank of #3, …

First Trust Advisors LP Purchases 44,713 Shares of Lantheus Holdings, Inc. $LNTH

First Trust Advisors LP significantly increased its stake in Lantheus Holdings, Inc. by 287.6% in Q1, acquiring 44,713 additional shares to hold a total of 60,258 shares valued at $4.57 million. This comes as Lantheus is set to be acquired by Curium for $102.50 …

Earnings Preview: AQST to Report Financial Results Post-market on August 11

AQST is scheduled to announce its financial results after the market closes on August 11. Investors will be closely watching the earnings report for insights into the company's performance and future outlook. This preview serves as a heads-up for those tracking AQST's financial news.

Lantheus Holdings: Q2 Earnings Snapshot

Lantheus Holdings Inc. reported strong second-quarter earnings, surpassing Wall Street expectations. The diagnostic imaging company posted a profit of $1.11 per share and adjusted earnings of $1.55 per share, exceeding analyst estimates of $1.33. Revenue for the quarter also beat forecasts, coming in at …

Lantheus' Q2 Adjusted Earnings Fall, Revenue Rises

Lantheus (LNTH) reported a decrease in its Q2 adjusted earnings per diluted share to $1.55, although the company saw an increase in its revenue for the same quarter. The article notes that further details are available for premium subscribers.

Stocks in play: Cronos Group Inc.

Cronos Group Inc. announced its 2026 second-quarter business results, reporting a 51% year-over-year increase in net revenue on an organic, constant-currency basis. Following this announcement, shares of Cronos Group Inc. (T.CRON) were trading up by $0.44 at $4.24.

Cumberland Pharmaceuticals (CPIX) Stock Cools As Cash Rich Biotech Pivot Begins

Cumberland Pharmaceuticals (CPIX) stock declined by 2.8% today, despite a significant strategic pivot. The company recently completed a $100 million divestiture and issued a $1.50 per share special dividend, transforming it into a cash-rich, development-focused biotech. While Q2 2026 showed operating and net losses, …

Pacira BioSciences, Inc. Stock 12‑Month Price Target Raised to $30, Implies 9% Upside

Pacira BioSciences, Inc.'s stock price target has been raised to $30 from $29.67 by 6 analysts, suggesting a 9% potential upside from its August 4 closing price. The consensus rating for PCRX remains a "Buy," with a breakdown of 3 Buys, 2 Holds, and …

Supernus Pharmaceuticals (SUPN) Jumps On Merger Terms, Is The Stock Still Cheap?

UBS Group Boosts Elanco Animal Health (NYSE:ELAN) Price Target to $33.00

Organogenesis: Q2 Earnings Snapshot

Zoetis Inc. Quarterly Earnings Report

Collegium Pharmaceutical (COLL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Viatris (NASDAQ:VTRS) Posts Better-Than-Expected Sales In Q2 CY2026

Viatris (Nasdaq: VTRS) grows Q2 revenue, raises 2026 outlook

Viatris (VTRS) Beats Q2 Earnings and Revenue Estimates

Perrigo (PRGO) Stock Reprices Fast As Profit Returns Meet Margin Pressure

Emergent BioSolutions (NYSE: EBS) posts Q2 loss, plans cost-cutting

Organogenesis (NASDAQ: ORGO) hit by 58% sales drop and $149M first-half loss

Organogenesis Expects 2026 Revenue Between $179M and $215M

Amphastar Pharmaceuticals (AMPH) Earnings Date and Reports 2026

Evotec (EVO) Projected to Post Earnings on Thursday

Cronos Group (CRON) Surpasses Q2 Earnings and Revenue Estimates

Cronos Group (Nasdaq: CRON) swings to profit and launches new share repurchase plan

Xeris Biopharma (NASDAQ:XERS) Shares Gap Down Following Weak Earnings

Amylyx Pharmaceuticals (NASDAQ:AMLX) Issues Earnings Results, Misses Estimates By $0.03 EPS

Royal Bank Of Canada Issues Pessimistic Forecast for BioCryst Pharmaceuticals (NASDAQ:BCRX) Stock Price